Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McIntosh & Kjernisted Clinical Research is a specialized clinical research site located in British Columbia, Canada, focusing on psychiatric and central nervous system (CNS) disorders. Founded by Dr. Diane McIntosh and Dr. Kevin Kjernisted, the organization conducts Phase II through Phase IV clinical trials in partnership with global pharmaceutical and biotechnology companies. The center's expertise covers a broad spectrum of mental health conditions, including major depressive disorder, generalized anxiety disorder, ADHD, and bipolar disorder. As a dedicated research facility, it provides comprehensive services such as patient screening, clinical assessment, and rigorous data management according to Good Clinical Practice (GCP) standards. The site is well-regarded for its high recruitment rates and its contribution to the clinical validation of numerous psychotropic medications currently on the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. D McIntosh & Dr. K Kjernisted Clinical Research.